Posts

The currency of conservation

Governments, nonprofit organizations, and other groups spend roughly $100 billio...

Wearable bracelet tracks bipolar mood swings: changing ...

Not peer-reviewed/experimental study/people Credit: redit: Diego Hidalgo-Mazzei ...

SUSTAIN Center at UH commemorates five years of combatt...

The SUSTAIN Wellbeing COMPASS Coordinating Center of the University of Houston G...

Zeiss and Boehringer Ingelheim have formed an AI-backed...

A recently established collaboration between Zeiss Medical Technology and Boehri...

Novartis Receives Great Reviews For Iptacon Phase 3 Per...

In the context of clinical trials, Novartis has achieved a significant milestone...

FDA Imposes Partial Clinical Hold on Innate Pharma’s Ly...

Innate Pharma, a prominent player in the biotechnology sector, has encountered a...

Fractyl’s GLP-1 Obesity Gene Therapy Performs Well in W...

During a presentation at the annual meeting of the European Association for the ...

FDA grants authorization to Invitae DNA test to identif...

The healthcare sector is undergoing rapid changes, with genetic testing leading ...

Lumicell co-founder wins Nobel Prize in Chemistry

The co-founder of a fluorescence-guided imaging technology firm has been awarde...

AstraZeneca’s Forxiga meets primary endpoint for T2D

AstraZeneca has announced positive results from the T2NOW Phase III trial for p...

Japanese Kyowa Kirin acquires Orchard to bolster gene t...

The Japan-based pharmaceutical company Kyowa Kirin has entered into a defin...

EMA endorses Calliditas’ Alport syndrome drug for orpha...

The European Medicines Agency (EMA) has provided a positive opinion for Callidi...

Inhibikase’s risvodetinib wins FDA orphan drug designation

The US Food and Drug Administration (FDA) has granted Inhibikase Therapeutics’ ...

Advanz Pharma to license Dimerix’s DMX-200 drug candidate

Advanz Pharma has signed an agreement to licence Dimerix’s drug candidate DMX-2...

Shorla raises funds to advance oncology drug candidates

US-Ireland speciality pharmaceutical company Shorla Oncology has received $35m ...

UK launches national full-body scan platform to acceler...

The UK national scanning programme, National PET Imaging Platform (NPIP), has b...